Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
This study has been withdrawn prior to recruitment.
Study NCT00006106 Information provided by National Cancer Institute (NCI)
First Received: August 3, 2000 Last Updated: January 11, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lip and Oral Cavity Cancer
Head and Neck Cancer
Oropharyngeal Cancer
Additional conditions recognized in this trial
Head and Neck Neoplasms
Lip Neoplasms
Oropharyngeal Neoplasms
More general conditions related to this trial
Lip Diseases
Mouth Diseases
Mouth Neoplasms
Neoplasms
Neoplasms by Site
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Pharyngeal Diseases
Pharyngeal Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
cisplatin
fluorouracil
ONYX-015
Additional drug interventions recognized in this trial
ONYX015
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Back to top of Main Content
